SCHEMBL4865282

SCHEMBL4865282

CCOC(CN(C(=O)CC(=O)OC)c1ccccc1)OCC

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 2/20 0.42
GLA P06280 1/20 0.42
TSHR P16473 1/20 0.42
TP53 P04637 1/20 0.42
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
OPRM1 P35372 4/20 0.38
CACNA1C Q13936 1/20 0.37
NPC1 O15118 1/20 0.37
JAK2 O60674 1/20 0.37
RAB9A P51151 1/20 0.37
PAX8 Q06710 1/20 0.37
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
MLYCD O95822 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4874740 0.88 ALDH1A1 (0.45) SMN1; SMN2ALDH1A1GLATSHRTP53
SCHEMBL4874004 0.86 ALDH1A1 (0.42) SMN1; SMN2ALDH1A1GLATSHRTP53
SCHEMBL8516064 0.82 ALDH1A1 (0.59) SMN1; SMN2ALDH1A1GLATSHRTP53
SCHEMBL5461474 0.76 NPC1 (0.61) SMN1; SMN2ALDH1A1GLAMEN1KMT2A
SCHEMBL10752510 0.74 SMN1; SMN2 (0.69) SMN1; SMN2ALDH1A1GLATSHRTP53
SCHEMBL8303367 0.74 HTT (0.52) SMN1; SMN2ALDH1A1MEN1KMT2AOPRM1
SCHEMBL3583408 0.74 TP53 (0.43) SMN1; SMN2ALDH1A1GLATSHRTP53
SCHEMBL325730 0.74 TSHR (0.53) SMN1; SMN2ALDH1A1GLATSHRTP53
SCHEMBL307080 0.72 KMT2A (0.50) ALDH1A1MEN1KMT2ACYP3A4CYP2C9
SCHEMBL7238334 0.71 KDM4E (0.41) ALDH1A1GLATSHRTP53MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442693-B2 Diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors SMITHKLINE BEECHAM CORPORATION (US) 2008-10-28 US disclosed
US-20070270411-A1 Novel Diazepine Compounds as Ligands of the Melanocortin 1 and/or 4 Receptors SMITHKLINE BEECHAM CORPORATION 2007-11-22 US disclosed
WO-2005118573-A1 NOVEL DIAZEPINE COMPOUNDS AS LIGANDS OF THE MELANOCORTIN 1 AND/OR 4 RECEPTORS SMITHKLINE BEECHAM CORPORATION (US) 2005-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270411-A1 Novel Diazepine Compounds as Ligands of the Melanocortin 1 and/or 4 Receptors MC4R, MC3R, MC5R SMN1; SMN2 3702/4885ALDH1A1 2986/4885GLA 4736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.